ASSESSMENT OF THE RESPONSE TO CHEMOTHERAPY IN ESOPHAGEAL CANCER

被引：14

作者：

WALKER, SJ ^{[1
]}

ALLEN, SM ^{[1
]}

STEEL, A ^{[1
]}

CULLEN, MH ^{[1
]}

MATTHEWS, HR ^{[1
]}

机构：

[1] E BIRMINGHAM DIST GEN HOSP,REG DEPT THORAC SURG,OESOPHAGEAL RES LAB,BIRMINGHAM B9 5ST,W MIDLANDS,ENGLAND

来源：

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 1991年 / 5卷 / 10期

关键词：

ESOPHAGEAL CANCER; CHEMOTHERAPY; SURGERY;

D O I：

10.1016/1010-7940(91)90104-R

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Thirty-eight patients with localised oesophageal carcinoma have been studied by computed tomography (CT) and barium swallow before and after preoperative chemotherapy and the results correlated with the pathological findings in the resected specimen. Overall 48% of patients showed a complete or partial response to chemotherapy on CT, compared with 50% on barium and 94% on pathological examination. This study highlights deficiencies in CT scanning and barium swallow as methods of assessing the regression of tumor bulk following chemotherapy for oesophageal carcinoma. We suggest that strict and specific criteria will have to be laid down before the results of chemotherapy in this disease can be reliably and accurately evaluated.

引用

页码：519 / 522

页数：4

共 10 条

[1]

Agha F.P., Gennis M.A., Orringer M.B., Forastiere A.A., Evaluation of response to preoperative chemotherapy in esophageal and gastric cancer using biphasic esophagrams and surgical-pathological correlation, Am J Clin Oncol, 9, 3, pp. 227-232, (1986)

[2]

Freeny P.C., Marks W.M., Adenocarcinoma of the gastroesophageal junction: Barium and CT examination, AJR, 138, pp. 1077-1084, (1982)

[3]

Kelsen D.P., Heelan R., Coonley C., Bains M., Martini N., Hilaris B., Golbey R.B., Clinical and pathological evaluation of response to chemotherapy in patients with oesophageal cancer, Am J Clin Oncol, 6, pp. 539-546, (1983)

[4]

Matthews H.R., Steel A., Left-sided subtotal oesophagec- tomy for carcinoma, Br J Surg, 74, pp. 1115-1117, (1987)

[5]

Miller A.B., Hoogstraten B., Staquet M., Winkler A., Reporting results of cancer treatment, Cancer, 47, pp. 207-214, (1981)

[6]

Moss A.A., Schnyder P., Thoeni P.F., Margulis A.R., Esophageal carcinoma: Pretherapy staging by computed tomography, AJR, 136, pp. 1051-1056, (1981)

[7]

Picus D., Balfe D.M., Koehler R.E., Roper C.L., Owen J.W., Computed tomography in the staging of esophageal carcinoma, Radiology, 146, pp. 433-438, (1983)

[8]

Quint L.E., Glazer G.M., Orringer M.B., Gross B.H., Esophageal carcinoma: CT findings, Radiology, 155, pp. 171-175, (1985)

[9]

Steel A., Cullen M.H., Robertson P.W., Matthews H.R., A phase II study of carboplatin in adenocarcinoma of the oesophagus, Br J Cancer, 58, pp. 500-501, (1988)

[10]

Thompson W.M., Halvorsen R.A., Foster W.L., Williford M.E., Postlethwait R.W., Korobkin M., Computed tomography for staging esophageal and gastroesophageal cancer, AJR, 141, pp. 951-958, (1983)

← 1 →